With its headquarters in India, Innova Captab is a full-service pharmaceutical company that works across the whole pharmaceutical value chain. This include participation in pharmaceutical product marketing and exports, as well as the manufacturing process, distribution, and research and development.

The company operates three businesses: (i) a domestic branded generics business; (ii) an international branded generics business; and (iii) a contract development and manufacturing organisation (CDMO) business that offers manufacturing services to Indian pharmaceutical companies.

As of the end of December 31, 2021, Innova Captab has 164 CDMO clients. The company manufactures more than 400 generic items in a diverse range that are sold in the Indian market under its own original names. This is made possible by a vast network that includes over 3,400 distributors and stockists in addition to a strong presence in over 96,000 retail pharmacies. 17 nations received shipments of branded generic goods from Innova Captab. At its research and development laboratory, the corporation employs 20 scientists and engineers full-time as of April 30, 2022.

Across the whole Indian subcontinent, Innova Captab distributes its nationally labelled generic medications through a vast network of distributors, retailers, and pharmacies. Furthermore, these generic medication products can be purchased online via a number of e-commerce pharmacy platforms. Sales of CDMO products have increased dramatically, rising on a restated consolidated basis by 97.90% from 954 in Fiscal 2019 to 1,888 in the nine months ending on December 31, 2021.